A new antiviral pill cuts COVID-19 hospitalization and death rates
Merck says its drug, molnupiravir, stops viral replication and can be taken right after a COVID-19 diagnosis.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
